0.85
+0.0015(+0.18%)
Currency In USD
| Previous Close | 0.85 |
| Open | 0.85 |
| Day High | 0.87 |
| Day Low | 0.82 |
| 52-Week High | 1.65 |
| 52-Week Low | 0.7 |
| Volume | 118,423 |
| Average Volume | 190,137 |
| Market Cap | 65.62M |
| PE | -1.81 |
| EPS | -0.47 |
| Moving Average 50 Days | 0.88 |
| Moving Average 200 Days | 1.03 |
| Change | 0 |
If you invested $1000 in Clearside Biomedical, Inc. (CLSD) since IPO date, it would be worth $117.12 as of May 09, 2025 at a share price of $0.849. Whereas If you bought $1000 worth of Clearside Biomedical, Inc. (CLSD) shares 5 years ago, it would be worth $428.84 as of May 09, 2025 at a share price of $0.849.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
GlobeNewswire Inc.
Yesterday at 11:05 AM GMT
ALPHARETTA, Ga., May 08, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal spac
Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
GlobeNewswire Inc.
May 01, 2025 11:05 AM GMT
ALPHARETTA, Ga., May 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that
Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire Inc.
Apr 01, 2025 11:05 AM GMT
ALPHARETTA, Ga., April 01, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today tha